Search Results for "health effects"

242 result(s) found

Scroll Down To Discover

Found 242 result(s)

© Image Copyrights Juris Services & Technology

Supreme Court Dismisses Petitions and Connected Matters, Upholds Government's AEFI Framework and Rejects Compensation Claims Under Article 32

The Supreme Court dismissed a batch of writ petitions and connected matters seeking compensation for deaths allegedly caused by COVID-19 vaccination -...

© Image Copyrights Juris Services & Technology

WRIT PETITION NO. 15903 OF 2024

...

© Image Copyrights Juris Services & Technology

"Landmark Judgment on Property Rights and Public Welfare in Mumbai" "Balancing property ownership with the collective good under India's constitutional framework."

The Supreme Court examined whether Chapter VIII-A of the MHADA Act aligns with the principles of Article 39(b) of the Indian Constitution, which aims ...

© Image Copyrights Juris Services & Technology

Protecting Consumer Clarity in Pharmaceutical Markets

The case involves a dispute over trademark infringement between the plaintiff's "ZITA-MET" and the defendant's "XIGAMET" in the pharmaceutical sector....

© Image Copyrights Juris Services & Technology

Supreme Court Allows Union of India's Appeals in Excise Duty Exemption Withdrawal Case — Doctrine of Promissory Estoppel Cannot Bar Withdrawal of Exemption in Public Interest. Public Interest Overrides Individual Interest When Withdrawal of Tax Exemption Is Based on Health Hazards.

The Supreme Court of India heard three civil appeals filed by the Union of India against judgments of the Sikkim High Court and the Gauhati High Court...

© Image Copyrights Juris Services & Technology

Supreme Court Upholds Quashing of Notification Restricting Oxytocin Manufacture to Public Sector. Notification under Section 26A of Drugs and Cosmetics Act, 1940 held invalid for being arbitrary and disproportionate to the objective of curbing misuse.

The case involves a challenge to a notification issued by the Ministry of Health and Family Welfare under Section 26A of the Drugs and Cosmetics Act, ...